ASMBS ANNUAL MEETING 2022 -- DALLAS - Scientific Theme – A Pathway to Cancer Prevention
American Society for Metabolic and Bariatric Surgery (ASMBS)The 38th annual meeting of the American Society for Metabolic and Bariatric Surgery (ASMBS)
The 38th annual meeting of the American Society for Metabolic and Bariatric Surgery (ASMBS)
Adults with obesity who had weight-loss surgery and achieved substantial weight loss prior to contracting COVID-19 reduced their risk for developing severe outcomes from the infection by 60% compared to those who did not have surgery, according to a new Cleveland Clinic study published online today in the journal JAMA Surgery.
A new Cleveland Clinic study shows that patients with obesity and advanced fatty liver disease who had bariatric surgery (weight-loss surgery) significantly lowered their risk for severe liver disease and serious cardiovascular disease, including heart attack and stroke, compared to patients who did not have the surgery.
The risk of stroke is cut by more than half in what researchers believe is the largest patient sample size ever for a study on bariatric surgery and its effect on ischemic cerebrovascular disease (96,094 bariatric surgery patients and 1,533,725 matched nonsurgical patients with obesity).
Long-Term Outcomes of Duodenal Switch (DS) Versus Single Anastomosis Duodeno-Ileostomy with Sleeve Gastrectomy (SADI-S): A Matched Cohort Study
Weight-loss surgery improves or resolves diseases including type 2 diabetes, heart disease and high blood pressure and can lead to significant and durable weight loss for many people, but the operation has largely been restricted to those with severe obesity, which means about 75 to 100 pounds overweight or a body mass index (BMI) of 35 or higher with an obesity-related disease.
A new study released today finds residents in several states with the highest obesity rates in the country are among the least likely to undergo weight-loss surgery, long considered the standard of care for severe obesity and related diseases including type 2 diabetes and heart disease.
Patients with obesity who swallowed gas-filled balloon capsules designed to help them eat less, lost 1.9 times more weight than patients who relied on diet, exercise and lifestyle therapy alone, according to new research* presented today at ObesityWeek 2016, the largest international event focused on the basic science, clinical application and prevention and treatment of obesity. The annual conference is hosted by the American Society for Metabolic and Bariatric Surgery (ASMBS) and The Obesity Society (TOS).
NEW ORLEANS – NOV. 4, 2016 – Weight-loss surgery patients who stick to a schedule of 3-, 6- and 12-month follow-up visits with their doctors see greater improvements or remission of their diabetes, high blood pressure and high cholesterol than patients who skip their visits, according to new research* presented today at ObesityWeek 2016, the largest international event focused on the basic science, clinical application and prevention and treatment of obesity. The annual conference is hosted by the American Society for Metabolic and Bariatric Surgery (ASMBS) and The Obesity Society (TOS).
Women have about a 20 percent less chance of developing heart disease after weight-loss surgery than men, according to new research* presented today at ObesityWeek 2016, the largest international event focused on the basic science, clinical application and prevention and treatment of obesity. The annual conference is hosted by the American Society for Metabolic and Bariatric Surgery (ASMBS) and The Obesity Society (TOS).
Understanding of Risks of Obesity is Improving, But Major Misperceptions About Causes and Treatments Persist
While the average hospital saw 30-day readmission rates for weight-loss surgery patients drop by about 14 percent, some hospitals had reductions as much as 32 percent after implementing a new quality improvement program, according to new research* presented today at ObesityWeek 2016, the largest international event focused on the basic science, clinical application and prevention and treatment of obesity. The annual conference is hosted by the American Society for Metabolic and Bariatric Surgery (ASMBS) and The Obesity Society (TOS).
Patients with severe obesity who have gastric bypass surgery reduce their risk of dying from obesity and other diseases by 48 percent up to 10 years after surgery, compared to similar patients who do not undergo the procedure, according to new research* presented today at ObesityWeek 2016, the largest international event focused on the basic science, clinical application and prevention and treatment of obesity. The annual conference is hosted by the American Society for Metabolic and Bariatric Surgery (ASMBS) and The Obesity Society (TOS).
Weight-loss surgery, long considered a treatment largely reserved for people with severe obesity, may also be a good and safe option for the treatment of uncontrolled type 2 diabetes in those who are overweight or have mild to moderate obesity, according to researchers from Cleveland Clinic in Ohio.
he American Society for Metabolic and Bariatric Surgery (ASMBS) and groups including The Obesity Society (TOS) and Academy for Nutrition and Dietetics (AND), filed a complaint this month with U.S. Health and Human Services (HHS) claiming the 27 states that deny coverage for bariatric surgery are in non-compliance with the Affordable Care Act (ACA) and that their failure to comply is discriminatory against women and people with disabilities, and violates the ban against denying coverage based on health status or a pre-existing condition.
A new gastric balloon that can be swallowed like a pill and then filled while in the stomach, helped patients lose more than 37 percent of their excess weight over four months, according to new research presented here at ObesityWeek 2015, the largest international event focused on the basic science, clinical application and prevention and treatment of obesity. The weeklong conference is hosted by the American Society for Metabolic and Bariatric Surgery (ASMBS) and The Obesity Society (TOS).
Most states do not cover bariatric surgery under the Affordable Care Act (ACA) despite the need for effective treatments for obesity and the minimal impact it has on monthly premiums, according to new research presented here at ObesityWeek 2015, the largest international event focused on the basic science, clinical application and prevention and treatment of obesity. The weeklong conference is hosted by the American Society for Metabolic and Bariatric Surgery (ASMBS) and The Obesity Society (TOS).
Both men and women see lasting improvements in their sex lives after bariatric surgery, according to a new study, funded by the National Institutes of Health (NIH) and presented here at ObesityWeek 2015, the largest international event focused on the basic science, clinical application and prevention and treatment of obesity. The weeklong obesity conference is hosted by the American Society for Metabolic and Bariatric Surgery (ASMBS) and The Obesity Society (TOS).
After weight-loss surgery, 57 percent of patients with significant mobility issues before surgery no longer had them and about 70 percent of those with severe knee and hip pain or disability, experienced improvements in joint specific pain and function, according to new study, funded by the National Institutes of Health (NIH), that followed patients for three years.
A new study based on national insurance claims in the United States found that patients with obesity who had gastric bypass surgery cut their healthcare costs by nearly 40 percent after four years, and by 80 percent, if they also had type 2 diabetes before surgery.